-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Downgrades Anebulo Pharmaceuticals to Hold

Benzinga·07/23/2025 21:41:37
Listen to the news
Maxim Group analyst Michael Okunewitch downgrades Anebulo Pharmaceuticals (NASDAQ:ANEB) from Buy to Hold.